Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1985 Jul;61(1):49–57.

The influence of lithium chloride on experimental autoimmune thyroid disease.

R A Hassman, J H Lazarus, C Dieguez, A P Weetman, R Hall, A M McGregor
PMCID: PMC1577238  PMID: 2994922

Abstract

Lithium administration is known to be associated with the development of thyroid dysfunction; it also exerts an effect on the immune system. The effect of lithium on experimental autoimmune thyroid disease was studied in female August rats. Following immunization with rat thyroglobulin in Freund's complete adjuvant, lithium chloride was administered i.p. for 30 days to four groups at varying stages of the disease. Control animals received i.p. saline. Anti-thyroglobulin antibody levels (measured by ELISA) were significantly increased in rats given lithium immediately post-immunization (group B) compared to control animals (661 +/- 42 OD vs 448 +/- 68; mean +/- s.e., P less than 0.02). In contrast, animals which received lithium during the spontaneous resolution of the disease (group D) showed a significant fall in anti-TG antibody compared to controls (99 +/- 15 vs 27 +/- 15; P less than 0.001). Anti-TG antibody levels remained undetectable in animals which received lithium but were not immunized. The splenic T cell blastogenic response (as measured following phytohaemagglutinin stimulation) was significantly increased in rats receiving lithium prior to and during immunization (group A) (stimulation index 63.4 +/- 6.9 vs 10.2 +/- 2.4; P less than 0.001). Spontaneous cell proliferation of splenic lymphocytes was decreased in two lithium treated groups (group A P less than 0.005, group C P less than 0.05). There was no alteration in splenic weight or the degree of thyroid lymphocytic infiltration in any of the treated group. Lithium exerted both positive and negative influences on the immune system in rats immunized with thyroglobulin in adjuvant but did not induce autoantibody production in normal rats.

Full text

PDF
49

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Birch C. R., Jolley D. J., Hay G. G., Dymock I. W. Lithium therapy and hypothyroidism. Br Med J. 1972 Oct 28;4(5834):233–233. doi: 10.1136/bmj.4.5834.233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Burman K. D., Dimond R. C., Earll J. M., Wright F. D., Wartofsky L. Sensitivity to lithium in treated Graves' disease: effects on serum T4, T3 and reverse T3. J Clin Endocrinol Metab. 1976 Sep;43(3):606–613. doi: 10.1210/jcem-43-3-606. [DOI] [PubMed] [Google Scholar]
  3. Creemers P., Rose N. R., Kong Y. M. Experimental autoimmune thyroiditis. In vitro cytotoxic effects of T lymphocytes on thyroid monolayers. J Exp Med. 1983 Feb 1;157(2):559–571. doi: 10.1084/jem.157.2.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Deniker P., Eyquem A., Bernheim R., Loo H., Delarue P. Thyroid autoantibody levels during lithium therapy. Neuropsychobiology. 1978;4(5):270–275. doi: 10.1159/000117640. [DOI] [PubMed] [Google Scholar]
  5. Emerson C. H., Dysno W. L., Utiger R. D. Serum thyrotropin and thyroxine concentrations in patients recieving lithium carbonate. J Clin Endocrinol Metab. 1973 Feb;36(2):338–346. doi: 10.1210/jcem-36-2-338. [DOI] [PubMed] [Google Scholar]
  6. Fernandez L. A., Fox R. A. Perturbation of the human immune system by lithium. Clin Exp Immunol. 1980 Sep;41(3):527–532. [PMC free article] [PubMed] [Google Scholar]
  7. Gelfand E. W., Dosch H. M., Hastings B., Shore A. Lithium: a modulator of cyclic AMP-dependent events in lymphocytes? Science. 1979 Jan 26;203(4378):365–367. doi: 10.1126/science.216075. [DOI] [PubMed] [Google Scholar]
  8. Hart D. A. Evidence that lithium ions can modulate lectin stimulation of lymphoid cells by multiple mechanisms. Cell Immunol. 1981 Mar 1;58(2):372–384. doi: 10.1016/0008-8749(81)90231-8. [DOI] [PubMed] [Google Scholar]
  9. Hart D. A. Modulation of concanavalin A stimulation of hamster lymphoid cells by lithium chloride. Cell Immunol. 1979 Mar 1;43(1):113–122. doi: 10.1016/0008-8749(79)90155-2. [DOI] [PubMed] [Google Scholar]
  10. Hart D. A. Potentiation of phytohemagglutinin stimulation of lymphoid cells by lithium. Exp Cell Res. 1979 Mar 1;119(1):47–53. doi: 10.1016/0014-4827(79)90333-1. [DOI] [PubMed] [Google Scholar]
  11. Ishizaka S., Möller G. Lithium chloride induces partial responsiveness to LPS in nonresponder B cells. Nature. 1982 Sep 23;299(5881):363–365. doi: 10.1038/299363a0. [DOI] [PubMed] [Google Scholar]
  12. Janković B. D., Lenert P., Mitrović K. Suppression of experimental allergic thyroiditis in rats treated with lithium chloride. Immunobiology. 1982 May;161(5):488–493. doi: 10.1016/S0171-2985(82)80051-X. [DOI] [PubMed] [Google Scholar]
  13. Johnstone E. C., Whaley K. Antinuclear antibodies in psychiatric illness: their relationship to diagnosis and drug treatment. Br Med J. 1975 Jun 28;2(5973):724–725. doi: 10.1136/bmj.2.5973.724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Keller S. E., Weiss J. M., Schleifer S. J., Miller N. E., Stein M. Suppression of immunity by stress: effect of a graded series of stressors on lymphocyte stimulation in the rat. Science. 1981 Sep 18;213(4514):1397–1400. doi: 10.1126/science.6973822. [DOI] [PubMed] [Google Scholar]
  15. Lazarus J. H., John R., Bennie E. H., Chalmers R. J., Crockett G. Lithium therapy and thyroid function: a long-term study. Psychol Med. 1981 Feb;11(1):85–92. doi: 10.1017/s0033291700053307. [DOI] [PubMed] [Google Scholar]
  16. Lindstedt G., Nilsson L. A., Wålinder J., Skott A., Ohman R. On the prevalence, diagnosis and management of lithium-induced hypothyroidism in psychiatric patients. Br J Psychiatry. 1977 May;130:452–458. doi: 10.1192/bjp.130.5.452. [DOI] [PubMed] [Google Scholar]
  17. McGregor A. M., Rennie D. P., Weetman A. P., Hassman R. A., Foord S. M., Dieguez C., Hall R. The influence of cyclosporin a on experimental autoimmune thyroid disease in the rat. Life Sci. 1983 Jan 3;32(1-2):97–108. doi: 10.1016/0024-3205(83)90177-7. [DOI] [PubMed] [Google Scholar]
  18. McLarty D. G., O'Boyle J. H., Spencer C. A., Ratcliffe J. G. Effect of lithium on hypothalamic-pituitary-thyroid function in patients with affective disorders. Br Med J. 1975 Sep 13;3(5984):623–626. doi: 10.1136/bmj.3.5984.623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Perrild H., Hegedüs L., Arnung K. Sex related goitrogenic effect of lithium carbonate in healthy young subjects. Acta Endocrinol (Copenh) 1984 Jun;106(2):203–208. doi: 10.1530/acta.0.1060203. [DOI] [PubMed] [Google Scholar]
  20. Presley A. P., Kahn A., Williamson N. Antinuclear antibodies in patients on lithium carbonate. Br Med J. 1976 Jul 31;2(6030):280–281. doi: 10.1136/bmj.2.6030.280-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rose N. R., Kong Y. C., Okayasu I., Giraldo A. A., Beisel K., Sundick R. S. T-cell regulation in autoimmune thyroiditis. Immunol Rev. 1981;55:299–314. doi: 10.1111/j.1600-065x.1981.tb00346.x. [DOI] [PubMed] [Google Scholar]
  22. Rosenthal N. E., Goodwin F. K. The role of the lithium ion in medicine. Annu Rev Med. 1982;33:555–568. doi: 10.1146/annurev.me.33.020182.003011. [DOI] [PubMed] [Google Scholar]
  23. Schou M., Amdisen A., Eskjaer Jensen S., Olsen T. Occurrence of goitre during lithium treatment. Br Med J. 1968 Sep 21;3(5620):710–713. doi: 10.1136/bmj.3.5620.710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Segal R. L., Rosenblatt S., Eliasoph I. Endocrine exophthalmos during lithium therapy of manic-depressive disease. N Engl J Med. 1973 Jul 19;289(3):136–138. doi: 10.1056/NEJM197307192890306. [DOI] [PubMed] [Google Scholar]
  25. Shenkman L., Borkowsky W., Holzman R. S., Shopsin B. Enhancement of lymphocyte and macrophage function in vitro by lithium chloride. Clin Immunol Immunopathol. 1978 Jun;10(2):187–192. doi: 10.1016/0090-1229(78)90026-0. [DOI] [PubMed] [Google Scholar]
  26. Shenkman L., Borkowsky W., Shopsin B. Lithium as an immunologic adjuvant. Med Hypotheses. 1980 Jan;6(1):1–6. doi: 10.1016/0306-9877(80)90025-0. [DOI] [PubMed] [Google Scholar]
  27. Singer I., Rotenberg D. Mechanisms of lithium action. N Engl J Med. 1973 Aug 2;289(5):254–260. doi: 10.1056/NEJM197308022890508. [DOI] [PubMed] [Google Scholar]
  28. Weetman A. P., McGregor A. M., Hall R. Thyroglobulin uptake and presentation by macrophages in experimental autoimmune thyroiditis. Immunology. 1983 Oct;50(2):315–318. [PMC free article] [PubMed] [Google Scholar]
  29. Weetman A. P., McGregor A. M., Rennie D. P., Hall R. Sites of autoantibody production in rats with thyroiditis. Immunology. 1982 Jun;46(2):465–472. [PMC free article] [PubMed] [Google Scholar]
  30. Weetman A. P., McGregor A. M., Rennie D. P., Hassman R., Hall R. The role of the spleen in experimental autoimmune thyroiditis. Clin Exp Immunol. 1984 Apr;56(1):135–142. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES